Molecular determinants of αVβ5 localization in flat clathrin lattices - role of αVβ5 in cell adhesion and proliferation.


Journal

Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 13 10 2021
accepted: 20 04 2022
pubmed: 10 5 2022
medline: 9 6 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

The vitronectin receptor integrin αVβ5 can reside in two distinct adhesion structures - focal adhesions (FAs) and flat clathrin lattices (FCLs). Here, we investigate the mechanism that regulates the subcellular distribution of β5 in keratinocytes and show that β5 has approximately 7- and 5-fold higher affinity for the clathrin adaptors ARH (also known as LDLRAP1) and Numb, respectively, than for the talin 1 (TLN1); all proteins that bind to the membrane-proximal NPxY motif of the β5 cytoplasmic domain. Using mass spectrometry, we identified β5 interactors, including the Rho GEFs p115Rho-GEF and GEF-H1 (also known as ARHGEF1 and ARHGEF2, respectively), and the serine protein kinase MARK2, depletion of which diminishes the clustering of β5 in FCLs. Replacement of two serine residues (S759 and S762) in the β5 cytoplasmic domain with phospho-mimetic glutamate residues causes a shift in the localization of β5 from FAs into FCLs without affecting the interactions with MARK2, p115Rho-GEF or GEF-H1. Instead, we demonstrate that changes in the actomyosin-based cellular contractility by ectopic expression of activated Rho or disruption of microtubules regulates β5 localization. Finally, we present evidence that β5 in either FAs or FCLs functions to promote adhesion to vitronectin, cell spreading, and proliferation.

Identifiants

pubmed: 35532004
pii: 275569
doi: 10.1242/jcs.259465
pmc: PMC9234671
pii:
doi:

Substances chimiques

Clathrin 0
Receptors, Vitronectin 0
Serine 452VLY9402

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 824.14.010
Organisme : Dutch Cancer Society
ID : 12143
Organisme : Dutch NWO X-omics Initiative
Organisme : Alexander von Humboldt Foundation
Organisme : Netherlands Cancer Institute

Informations de copyright

© 2022. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Exp Cell Res. 1994 Sep;214(1):303-12
pubmed: 7521845
Int J Cancer. 2013 Nov 15;133(10):2362-71
pubmed: 23661241
Mol Biol Cell. 2002 Oct;13(10):3627-45
pubmed: 12388762
Biophys J. 2020 Apr 21;118(8):1977-1991
pubmed: 32191864
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Int J Clin Exp Pathol. 2013 Nov 15;6(12):2719-32
pubmed: 24294359
Oncotarget. 2017 Aug 18;8(44):77061-77074
pubmed: 29100370
Cell. 2002 Sep 20;110(6):673-87
pubmed: 12297042
J Biol Chem. 2010 Jul 30;285(31):23699-710
pubmed: 20507994
J Cell Sci. 2003 May 15;116(Pt 10):1991-2003
pubmed: 12679384
Dev Cell. 2018 Apr 9;45(1):132-145.e3
pubmed: 29634933
J Cell Biol. 2017 Nov 6;216(11):3785-3798
pubmed: 28912124
J Struct Biol. 2011 Aug;175(2):113-9
pubmed: 21453775
Mol Biol Cell. 2008 May;19(5):2147-53
pubmed: 18287519
Elife. 2016 Jan 27;5:e10130
pubmed: 26821125
Curr Biol. 2013 Nov 18;23(22):2288-2295
pubmed: 24210614
J Cell Biol. 1998 Jul 13;142(1):271-84
pubmed: 9660880
J Biol Chem. 2011 Dec 30;286(52):44576-84
pubmed: 22072711
J Cell Biol. 1991 May;113(4):919-29
pubmed: 1709170
J Cell Sci. 2018 Nov 5;131(21):
pubmed: 30301780
Bioessays. 2020 Nov;42(11):e2000119
pubmed: 32830356
J Cell Sci. 2020 Jun 4;133(11):
pubmed: 32499318
J Cell Biol. 2008 May 5;181(3):439-46
pubmed: 18458155
Science. 2015 Nov 27;350(6264):1092-6
pubmed: 26472760
Mol Biol Cell. 2014 Nov 5;25(22):3581-94
pubmed: 25165141
Am J Pathol. 1997 May;150(5):1631-46
pubmed: 9137089
Nat Commun. 2017 Jul 13;8:16068
pubmed: 28703125
Nat Cell Biol. 2002 Apr;4(4):294-301
pubmed: 11912491
Am J Physiol Cell Physiol. 2006 Apr;290(4):C1256-62
pubmed: 16338970
Nat Commun. 2022 Feb 16;13(1):905
pubmed: 35173166
Nat Cell Biol. 2018 Nov;20(11):1290-1302
pubmed: 30361699
Clin Respir J. 2015 Oct;9(4):457-67
pubmed: 24815623
J Cell Biol. 2019 Jul 1;218(7):2086-2095
pubmed: 31208994
J Cell Sci. 2013 Oct 15;126(Pt 20):4671-83
pubmed: 23902687
J Biol Chem. 2012 Jul 13;287(29):24585-94
pubmed: 22648415
Cancer Res. 2018 Aug 1;78(15):4396-4410
pubmed: 29844118
J Neurosci. 2001 Dec 15;21(24):RC187
pubmed: 11734602
J Cell Biol. 2020 Sep 7;219(9):
pubmed: 32642759
J Cell Biol. 2000 May 15;149(4):969-82
pubmed: 10811835
Nat Commun. 2018 Sep 20;9(1):3825
pubmed: 30237420
Nat Med. 2008 Mar;14(3):325-30
pubmed: 18278053
J Cell Sci. 1993 Dec;106 ( Pt 4):1083-102
pubmed: 8126093
Mol Biol Cell. 2019 Mar 1;30(5):579-590
pubmed: 30601711
Eur J Cancer. 2005 May;41(7):1065-72
pubmed: 15862757
Proc Natl Acad Sci U S A. 2019 Dec 10;:
pubmed: 31822619
Clin Cancer Res. 1999 Jun;5(6):1587-94
pubmed: 10389948
J Cell Biol. 2001 Mar 5;152(5):923-34
pubmed: 11238449
FEBS J. 2017 Oct;284(20):3355-3361
pubmed: 28796323
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Structure. 2010 Dec 8;18(12):1654-66
pubmed: 21134644
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2272-7
pubmed: 12606711
EMBO J. 1999 Feb 1;18(3):578-85
pubmed: 9927417
BMC Biotechnol. 2013 Feb 14;13:12
pubmed: 23410102
Sci Adv. 2020 Jan 22;6(4):eaax7413
pubmed: 32010782
Biol Open. 2020 Aug 13;9(8):
pubmed: 32709696
J Struct Biol. 2016 Oct;196(1):48-56
pubmed: 27431447
J Cell Biol. 2002 Sep 30;158(7):1287-97
pubmed: 12356872
Mol Cell Biol. 2000 Feb;20(3):755-9
pubmed: 10629031
Oncogene. 2013 Jun 20;32(25):3049-58
pubmed: 22824793
J Cell Biol. 2020 Feb 3;219(2):
pubmed: 31914171
Nat Cell Biol. 2012 May 06;14(6):584-92
pubmed: 22561348
Small GTPases. 2021 Sep-Nov;12(5-6):358-371
pubmed: 33126816
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Cell Biol. 2022 May;24(5):723-736
pubmed: 35469017
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
J Cell Biol. 1996 Jun;133(6):1205-15
pubmed: 8682859

Auteurs

Alba Zuidema (A)

Division of Cell Biology I, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.

Wei Wang (W)

Division of Cell Biology I, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.

Maaike Kreft (M)

Division of Cell Biology I, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.

Onno B Bleijerveld (OB)

Proteomics Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.

Liesbeth Hoekman (L)

Proteomics Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.

Jonas Aretz (J)

Department of Molecular Medicine, Max Planck Institute of Biochemistry, Am Klopfespitz 18, 82152 Martinsried, Germany.

Ralph T Böttcher (RT)

Department of Molecular Medicine, Max Planck Institute of Biochemistry, Am Klopfespitz 18, 82152 Martinsried, Germany.

Reinhard Fässler (R)

Department of Molecular Medicine, Max Planck Institute of Biochemistry, Am Klopfespitz 18, 82152 Martinsried, Germany.

Arnoud Sonnenberg (A)

Division of Cell Biology I, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.

Articles similaires

Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

Lisa Demoen, Filip Matthijssens, Lindy Reunes et al.
1.00
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Animals Mice Humans Cell Line, Tumor
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition

Classifications MeSH